GRI Bio Featured in "Why Now" On-Demand Video Webcast
GRI Bio, a biotechnology company listed on NASDAQ, announced its feature in the 'Why Now' on-demand video webcast, showcasing its work on developing therapies for inflammatory, fibrotic, and autoimmune diseases.